Increased asymmetric dimethylarginine (ADMA) levels and insulin resistance in non-diabetic stage I kidney disease

被引：0
作者：
Yilmaz, Mahmut Ilker
Caglar, Kayser
Sonmez, Alper
Cakir, Erdinc
Kaya, Ayper
Acikel, Cengizhan
Eyileten, Tayfun
Yenicesu, Mujdat
Oguz, Yusuf
Bilgi, Cumhur
Oktenli, Cagatay
Vural, Abdulgaffar
Zoccali, Carmine
机构：
[1] Gulhane Sch Med, Ankara, Turkey
[2] CNR, IBIM, Reggio Di Calabria, Italy
[3] Inst Biomed Clin Epidemiol & Pathophysiol Renal D, Reggio Di Calabria, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
[21]   Insulin resistance, ADMA levels, and cardiovascular disease [J].
Nash, DT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (11) :1451-1452
[22]   Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals [J].
Johns, Barry R. ;
Pao, Alan C. ;
Kim, Sun H. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (04) :1410-1415
[23]   Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients [J].
Lee, Seoung Woo ;
Park, Geun Ho ;
Lee, Seung Won ;
Song, Joon Ho ;
Hong, Kee Chun ;
Kim, Moon-Jae .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (09) :2554-2562
[24]   Insulin resistance in non-diabetic people with Parkinson's disease [J].
Tagliati, M. ;
Tan, E. ;
Eskenazi, J. ;
Basile, C. ;
Hogg, E. .
MOVEMENT DISORDERS, 2017, 32
[25]   Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology [J].
Boga, Salih ;
Alkim, Huseyin ;
Koksal, Ali Riza ;
Bayram, Mehmet ;
Ozguven, Muveddet Banu Yilmaz ;
Ergun, Meltem ;
Neijmann, Sebnem Tekin ;
Ozgon, Gulay ;
Alkim, Canan .
JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (07) :871-877
[26]   Increased asymmetric dimethylarginine (ADMA) levels and decreased homocysteine thiolactonase/paraoxonase (HTLase/PONase) activities are related to the risk of cardiovascular disease in prediabetic/diabetic patients [J].
Bayrak, Tulin ;
Bayrak, Ahmet ;
Isildak, Mehlika ;
Cakir, Erdinc ;
Gurlek, Alper ;
Akbiyik, Filiz .
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2014, 39 (03) :270-276
[27]   Unchanged asymmetric dimethylarginine levels in non-diabetic, premenopausal obese women who have common risk factors for cardiovascular disease [J].
P. Cetinalp-Demircan ;
A. Can ;
Selda Bekpinar ;
Y. Unlucerci ;
Y. Orhan .
Endocrine, 2007, 31 :100-104
[28]   Unchanged asymmetric dimethylarginine levels in non-diabetic, premenopausal obese women who have common risk factors for cardiovascular disease [J].
Cetinalp-Demircan, P. ;
Can, A. ;
Bekpinar, Selda ;
Unlucerci, Y. ;
Orhan, Y. .
ENDOCRINE, 2007, 31 (02) :100-104
[29]   Asymmetric dimethylarginine (ADMA) accelerates progression of chronic kidney disease by enhancing capillary rarefaction [J].
Matsumoto, Yuriko ;
Ueda, Seiji ;
Yamagishi, Sho-ichi ;
Matsuguma, Kyoko ;
Miyazaki, Hiroshi ;
Aoyagi, Fumiko ;
Okuda, Seiya .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 :6-6
[30]   ASYMMETRIC DIMETHYLARGININE (ADMA) AND PROGRESSION OF CHRONIC KIDNEY DISEASE: THE MILD TO MODERATE KIDNEY FAILURE (MMKF) STUDY [J].
Kielstein, Jan T. ;
Kronenberg, Florian ;
Fliser, Danilo ;
Bode-Boeger, Stefanie M. ;
Ritz, Eberhardt .
NEPHROLOGY, 2005, 10 :A236-A236
12345